Trials / Conditions / Recurrent Pregnancy Loss

Recurrent Pregnancy Loss

52 registered clinical trials studyying Recurrent Pregnancy Loss — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Study of Endometrial Immune and Microbiological Modifications in Cases of Recurrent Implantation Failure and/o NCT07265505	Assistance Publique - Hôpitaux de Paris	N/A
Not Yet Recruiting	Cardiac Autonomic and Anxiety Regulation Via Closed-loop nEurofeedback in Recurrent Pregnancy Loss NCT07325370	Shenyang Medical College	N/A
Recruiting	Effects of High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardia NCT06968026	Shenyang Jinghua Hospital	N/A
Recruiting	Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab NCT06652113	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	N/A
Recruiting	Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages NCT05725512	Leiden University Medical Center	Phase 4
Recruiting	Tender Loving Care for Recurrent Pregnancy Loss NCT06182878	Walter Reed National Military Medical Center	N/A
Unknown	Elucidating the Microbiome in Patients With Recurrent Pregnancy Loss NCT05612620	Assuta Ashdod Hospital	—
Unknown	Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells NCT05520112	Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus	Phase 1 / Phase 2
Unknown	Biweekly Follow-Up and At-Home Ultrasound Reduce Anxiety in Women With Recurrent Pregnancy Loss NCT05656846	Wolfson Medical Center	N/A
Recruiting	Prospective Recurrent Pregnancy Loss Registry NCT05989178	University of British Columbia	—
Unknown	Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL NCT05341856	Al-Azhar University	EARLY_Phase 1
Active Not Recruiting	Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss NCT06007560	Radboud University Medical Center	N/A
Unknown	Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss NCT05237843	Ain Shams University	Phase 1
Not Yet Recruiting	On Pregnancy After Losses - OPAL Study NCT05167812	Leiden University Medical Center	—
Completed	Evaluation of Apelin-13 and Apelin-36 in Women With Recurrent Pregnancy Loss NCT05205044	Ain Shams University	—
Unknown	Establishment of Special Disease Cohort for RPLand Study of Impact Mechanism of Early Embryo Development NCT05186207	Women's Hospital School Of Medicine Zhejiang University	—
Terminated	Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy NCT05186779	Center for Epidemiology and Health Research, Germany	—
Recruiting	Genomic Predictors of Recurrent Pregnancy Loss NCT05444283	Yale University	—
Completed	Intravenous Immunoglobulin and Prednisolone for RPL After ART. NCT04701034	Aalborg University Hospital	Phase 2
Active Not Recruiting	Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates NCT04744025	Lawrence Engmann	N/A
Completed	B-vitamin Levels and Adverse Pregnancy Outcomes NCT05073978	Westlake University	—
Unknown	Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss NCT04621773	Peking University Third Hospital	—
Completed	Hysteroscopic Septoplasty by Different Modalities NCT05802784	Mansoura University Hospital	N/A
Suspended	SCUBE-1 and Carotid Intima Media Thickness in Recurrent Pregnancy Loss NCT04397042	Recep Tayyip Erdogan University Training and Research Hospital	—
Completed	Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss NCT04455256	Kanuni Sultan Suleyman Training and Research Hospital	—
Unknown	Immunosuppressant Regimens for Living Fetuses Study NCT03671174	RenJi Hospital	N/A
Unknown	Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfrac NCT02144064	Benha University	Phase 3
Unknown	Meditation and Mindfulness for Recurrent Pregnancy Loss NCT03905395	Henriette Svarre Nielsen, MD, DMSc	N/A
Unknown	Use of Metabolomics for the Identification of Endometrial Biomarkers for IRPL and RIF After in Vitro Fertiliza NCT03690830	University Hospital, Angers	N/A
Completed	Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnanc NCT04718233	Ain Shams University	Phase 2
Unknown	Effects of PGS2.0 in Patients With Unexplained RPL NCT03214185	ShangHai Ji Ai Genetics & IVF Institute	N/A
Unknown	Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss NCT03305263	Rigshospitalet, Denmark	Phase 3
Completed	Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility NCT03401918	Stanford University	Phase 2
Completed	Ultrasound Predictors of Early Pregnancy Failure in Patients With Recurrent Pregnancy Loss NCT03178682	Ain Shams University	—
Unknown	The Epidemiology of Recurrent Spontaneous Abortion Associated With Thrombophilla NCT02990390	Shanghai First Maternity and Infant Hospital	—
Completed	Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss NCT03174951	Tabriz University of Medical Sciences	Phase 2
Withdrawn	Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss NCT02379650	University of Utah	Phase 2
Recruiting	Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction NCT05169541	Aalborg University Hospital	—
Completed	Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL) NCT04017754	Aalborg University Hospital	—
Completed	Association of HY-restricting HLA Class II Alleles, Sex of Firstborn Child, and Pregnancy Outcome in RPL Patie NCT05342948	Aalborg University Hospital	—
Unknown	Recurrent Pregnancy Loss and Thyroid Disease NCT03106935	Second Affiliated Hospital of Soochow University	EARLY_Phase 1
Completed	TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure NCT02386384	Eastern Virginia Medical School	—
Unknown	The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss NCT02990403	Shanghai First Maternity and Infant Hospital	Phase 4
Unknown	A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Rec NCT02156063	Nora Therapeutics, Inc.	Phase 2
Unknown	Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis NCT01946945	Reprogenetics	Phase 2
Completed	Sperm DNA Fragmentation in Recurrent Pregnancy Loss NCT02572154	University Hospital, Toulouse	N/A
Suspended	Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH NCT01546350	Reprogenetics	Phase 2
Unknown	Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages NCT01635426	Ain Shams University	Phase 2 / Phase 3
Terminated	Efficacy of a Structured Weight Loss Program in Overweight Women With a History of Recurrent Pregnancy Loss NCT01325805	Stanford University	N/A
Completed	Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment NCT01542411	Yazd Medical University	—
Completed	Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy NCT00721591	University of Chicago	—
Terminated	Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT NCT00564174	Mount Sinai Hospital, Canada	N/A